single page -

Data Table

Quarterly Table

Date Begin	Date End	Net Sales	Net Profit	Total Income	Diluted EPS for continuing operation	Other Expenses	Other Income	Depreciation and amortisation expense	Profit (+)/ Loss (-) from Ordinary Activities before Tax
2024-01-01	2024-03-31	2,532.37	91.17	2,577.80	1.32	-450.44	45.43	-43.04	125.25
2023-10-01	2023-12-31	1,938.54	96.18	1,958.59	1.30	-383.81	20.05	-38.96	124.69
2023-10-01	2023-12-31	2,103.18	85.19	2,124.23	1.14	-358.32	21.04	-38.27	113.48
2023-07-01	2023-09-30	2,529.34	119.28	2,583.43	1.75	-381.92	54.09	-34.70	164.90
2023-07-01	2023-09-30	2,257.27	129.11	2,310.79	1.89	-359.60	53.52	-34.02	174.18
2023-04-01	2023-06-30	2,423.60	129.90	2,457.51	1.78	-341.51	33.91	-35.19	173.30
2023-04-01	2023-06-30	2,436.17	121.50	2,478.02	1.66	-371.26	41.85	-35.86	165.74
2023-01-01	2023-03-31	2,345.71	171.28	2,365.34	2.44	-357.08	19.63	-44.36	233.12
2023-01-01	2023-03-31	2,343.01	171.01	2,360.66	2.43	-325.12	17.65	-43.81	233.85
2022-10-01	2022-12-31	2,064.11	43.11	2,070.32	0.56	-356.22	6.21	-44.79	60.60
2022-10-01	2022-12-31	2,111.25	104.05	2,118.32	1.42	-376.74	7.07	-45.34	123.01
2022-07-01	2022-09-30	2,294.23	56.13	2,300.83	0.80	-394.19	6.60	-42.87	80.53
2022-07-01	2022-09-30	2,410.42	48.98	2,419.38	0.70	-433.63	8.96	-43.35	83.38
2022-04-01	2022-06-30	2,582.70	84.85	2,589.37	1.22	-476.34	6.68	-40.08	128.39
2022-04-01	2022-06-30	2,519.27	110.07	2,525.07	1.58	-444.29	5.80	-39.72	151.14
2022-01-01	2022-03-31	2,214.20	84.33	2,227.56	1.22	-415.18	13.36	-38.85	120.49
2022-01-01	2022-03-31	2,137.99	22.97	2,147.57	0.35	-439.67	9.59	-39.20	55.12
2021-10-01	2021-12-31	1,954.93	43.82	1,985.31	1.20	-373.69	30.38	-35.72	62.84
2021-10-01	2021-12-31	2,115.71	96.84	2,148.84	2.70	-406.97	33.13	-36.03	123.41
2021-07-01	2021-09-30	1,835.93	39.40	1,856.60	1.12	-399.75	20.67	-34.37	54.98
2021-07-01	2021-09-30	1,805.65	36.12	1,825.14	1.03	-384.14	19.48	-34.09	47.96
2021-04-01	2021-06-30	1,827.05	84.82	1,866.62	2.37	-299.98	39.57	-30.97	120.55
2021-04-01	2021-06-30	1,770.74	71.29	1,810.93	1.99	-321.51	40.18	-31.26	111.64
2021-01-01	2021-03-31	1,556.40	145.56	1,577.54	4.33	-285.04	21.13	73.60	186.52
2021-01-01	2021-03-31	1,562.94	160.31	1,587.78	4.74	-303.00	24.83	73.54	207.34
2020-10-01	2020-12-31	1,421.92	123.15	1,455.50	3.35	-263.84	33.58	-62.20	145.06
2020-10-01	2020-12-31	1,409.93	85.03	1,441.38	2.27	-249.02	31.44	-61.73	107.19
2020-07-01	2020-09-30	1,363.89	62.06	1,374.58	1.84	-221.00	10.69	-64.29	87.72
2020-07-01	2020-09-30	1,366.91	63.44	1,381.50	1.88	-236.06	14.58	-64.61	94.72
2020-04-01	2020-06-30	1,063.32	37.84	1,071.15	0.97	-181.10	7.84	-58.22	49.32
2020-04-01	2020-06-30	1,053.54	28.54	1,061.12	0.71	-193.99	7.58	-58.53	42.75
2020-01-01	2020-03-31	1,208.15	17.20	1,223.25	0.43	-234.48	15.10	-55.81	21.98
2020-01-01	2020-03-31	1,109.93	21.83	1,124.57	0.56	-221.63	14.64	-55.13	22.73
2019-10-01	2019-12-31	1,138.72	21.73	1,148.13	0.70	-220.17	9.41	-49.98	31.21
2019-10-01	2019-12-31	1,126.25	32.85	1,137.27	0.97	-203.71	11.03	-49.07	43.03
2019-07-01	2019-09-30	1,086.50	41.27	1,109.29	1.11	-195.93	22.79	-43.20	52.10
2019-07-01	2019-09-30	1,118.66	43.94	1,142.48	1.18	-212.77	23.82	-44.12	54.76
2019-04-01	2019-06-30	1,277.39	50.16	1,296.07	1.50	-191.47	18.68	-42.57	77.13
2019-04-01	2019-06-30	1,302.90	48.41	1,320.32	1.45	-203.93	17.42	-43.44	78.58
2019-01-01	2019-03-31	1,330.12	52.30	1,337.51	1.60	-179.34	7.39	-40.90	77.47
2018-10-01	2018-12-31	1,201.58	71.11	1,220.26	2.06	-187.48	18.67	-32.53	107.19
2018-07-01	2018-09-30	1,180.07	61.78	1,184.00	-	-191.91	3.93	-31.69	99.23
2018-04-01	2018-06-30	997.29	42.21	1,003.07	-	-154.10	5.79	-30.18	64.86
2018-01-01	2018-03-31	897.05	37.73	898.34	-	-143.80	1.29	-32.94	54.02
2017-10-01	2017-12-31	928.99	22.99	931.07	-	-156.94	2.08	-27.50	60.10
2017-07-01	2017-09-30	858.80	59.10	867.72	-	-133.65	8.92	-28.81	85.31
2017-04-01	2017-06-30	812.67	22.80	824.44	-	-168.83	11.76	-26.81	30.32
2017-01-01	2017-03-31	799.11	39.82	817.35	-	-127.16	18.24	-30.59	57.14
2016-10-01	2016-12-31	647.30	28.34	-	-	-85.84	-	-29.52	32.97
2016-07-01	2016-09-30	684.66	37.33	-	-	-90.83	-	-28.28	61.66

Date Begin	Date End	Net Sales	Net Profit	Total Income	Diluted EPS for continuing operation	Other Expenses	Other Income	Depreciation and amortisation expense	Profit (+)/ Loss (-) from Ordinary Activities before Tax
2024-01-01	2024-03-31	2,532.37	91.17	2,577.80	1.32	-450.44	45.43	-43.04	125.25
2023-10-01	2023-12-31	2,103.18	85.19	2,124.23	1.14	-358.32	21.04	-38.27	113.48
2023-10-01	2023-12-31	1,938.54	96.18	1,958.59	1.30	-383.81	20.05	-38.96	124.69
2023-07-01	2023-09-30	2,257.27	129.11	2,310.79	1.89	-359.60	53.52	-34.02	174.18

Compounded Sales Growth
10 Years:	16%
5 Years:	12%
3 Years:	20%
TTM:	0%

Compounded Profit Growth
10 Years:	22%
5 Years:	13%
3 Years:	11%
TTM:	17%

Stock Price CAGR
10 Years:	31%
5 Years:	28%
3 Years:	17%
1 Year:	19%

Compounded Sales Growth
10 Years:	16%
5 Years:	12%
3 Years:	20%
TTM:	0%

Compounded Profit Growth
10 Years:	22%
5 Years:	11%
3 Years:	5%
TTM:	6%

Stock Price CAGR
10 Years:	31%
5 Years:	28%
3 Years:	17%
1 Year:	19%

Latest News

Indo Amines Sets Up New Unit for Manufacturing API Intermediates
Indo Amines Limited, a leading manufacturer of speciality chemicals, has set up a new manufacturing unit dedicated to the production of API (Active Pharmaceutical Ingredient) intermediates. The new unit is located at the Company's existing manufacturing facility in Dahej, Gujarat, India.
Indo Amines' Revenue Increases by 15% in Q3 FY23
Indo Amines Limited (IAL) reported a 15% increase in revenue for the third quarter (Q3) of the financial year 2022-23 (FY23). The Company's revenue for Q3 FY23 stood at Rs. 363.66 crores, compared to Rs. 316.26 crores in Q3 FY22.
Indo Amines Receives USFDA Approval for its Sterile Injectable Facility
Indo Amines Limited (IAL) has received approval from the United States Food and Drug Administration (USFDA) for its sterile injectable manufacturing facility located at Dahej, Gujarat, India. The approval is a significant milestone for the Company, enabling it to enter the global market for sterile injectable products.
Indo Amines Limited to Acquire Controlling Interest in Chembond Chemicals Limited
INDO AMINES LIMITED has entered into an agreement to acquire the controlling interest in Chembond Chemicals Limited (CCL). The acquisition will be made through a combination of primary and secondary share purchase.
Indo Amines Limited Declares Revised Date for Board Meeting
This is to inform you that a meeting of the Board of Directors of Indo Amines Limited is scheduled to be held on Tuesday, 18th April, 2023 instead of Thursday, 20th April, 2023.
Indo Amines Limited Receives Environmental Clearance for Expansion Project
The Company has received Environmental Clearance for its proposed capacity expansion project at Dahej SEZ, Gujarat from Gujarat Pollution Control Board. The project involves setting up of a new manufacturing unit for production of 18,000 MTPA of Ethyl Amine and 10,000 MTPA of Diethyl Amine.
Indo Amines Ltd. Q3FY23 Consolidated PAT stood at Rs 117.52 crores, up by 27% YoY
Indo Amines Ltd. has reported a 27% YoY growth in its consolidated PAT to Rs 117.52 crores for the third quarter ended December 31, 2022. The company's revenue from operations during the quarter grew by 17% YoY to Rs 614.26 crores.
Indo Amines Ltd. announces Q2FY23 results: Revenue up 13%, PAT up 22%
Indo Amines Ltd., a leading manufacturer of specialty chemicals in India, announced its financial results for the second quarter ended September 30, 2022. The company reported a 13% YoY growth in its revenue from operations to Rs 543.45 crores. The company's PAT for the quarter grew by 22% YoY to Rs 91.81 crores.
Indo Amines Ltd. collaborates with Evonik to launch new specialty chemicals plant in India
Indo Amines Ltd., a leading manufacturer of specialty chemicals in India, has announced a collaboration with Evonik, a global leader in specialty chemicals, to launch a new specialty chemicals plant in India. The new plant will produce a range of specialty chemicals that will be used in a variety of industries, including pharmaceuticals, food and beverage, and personal care.
Indo Amines Reports Strong Q3 FY23 Performance, Revenue Up 23%
Indo Amines, a leading manufacturer of specialty chemicals, has reported strong financial performance for the third quarter of fiscal year 2023. The company's revenue increased by 23% year-over-year to Rs. 278.86 crore, driven by robust demand for its products across various end-use industries.
Indo Amines Q3 Results: Net Profit Up 30%, Company Maintains Strong Momentum
Indo Amines has reported a 30% increase in its net profit for the third quarter of fiscal year 2023. The company's net profit stood at Rs. 41.76 crore, compared to Rs. 32.05 crore in the corresponding quarter of the previous year.
Indo Amines Q3 Revenue Surges 23%, Company on Track to Meet FY23 Guidance
Indo Amines has announced a 23% increase in its revenue for the third quarter of fiscal year 2023. The company's revenue stood at Rs. 278.86 crore, up from Rs. 226.65 crore in the corresponding quarter of the previous year.
Indo Amines receives SEBI's approval for Rs 120 cr preferential issue
Indo Amines has received the Securities and Exchange Board of India's (SEBI's) approval for its proposed preferential issue of equity shares to raise up to Rs 120 crore.
Indo Amines to invest Rs 250 crore in manufacturing facility in Dahej
Indo Amines Ltd, a leading manufacturer of speciality chemicals, plans to invest Rs 250 crore in setting up a new manufacturing facility at Dahej in Gujarat.
Indo Amines' net profit rises 22% to Rs 23 crore in Q1 FY23
Indo Amines Ltd has reported a 22% rise in its net profit to Rs 23 crore for the first quarter ended June 30, 2022, on the back of higher sales.
Indo Amines signs MOU with Dorf Ketal to distribute its products in India
Indo Amines Ltd has signed a Memorandum of Understanding (MOU) with Dorf Ketal Chemicals India Pvt Ltd to distribute its products in India.
Indo Amines launches new product range for personal care industry
Indo Amines Ltd has launched a new range of products for the personal care industry, including hair care, skin care, and oral care products.
Indo Amines Ltd. Announces Q3 FY23 Results
The company reported a strong set of financial results for the third quarter of fiscal year 2023, driven by robust demand for its products and operational efficiencies.
Indo Amines Ltd. Partners with Global Distributor for Expansion in Europe
The company has entered into a strategic partnership with a leading global distributor to expand its presence in the European market.
Indo Amines Ltd. Commissions New Manufacturing Facility
The company has successfully commissioned its new manufacturing facility, which will significantly increase its production capacity.
Indo Amines Ltd. Receives Industry Recognition for Sustainability Practices
The company has been recognized by the industry for its commitment to sustainability and environmental stewardship.
Indo Amines Ltd. Reports Strong H1 FY23 Results
The company announced strong financial results for the first half of fiscal year 2023, driven by increased sales and improved margins.

Indo Amines Ltd.

Short Description

Long Description

Price Chart

Volume Chart

Peer Comparison

Peer Comparison Chart

Quarterly Table

Latest News